Cetuximab Alone or With Irinotecan for Resistant KRAS-, NRAS-, BRAF- and PIK3CA-wild-type Metastatic Colorectal Cancer: The AGITG Randomized Phase II ICECREAM Study Journal Articles Refereed uri icon

Overview

Published in

  • Clinical Colorectal Cancer

Time

Date/time value

  • 2018

Identity

Digital Object Identifier (DOI)

  • 10.1016/j.clcc.2018.06.002

Additional Document Info

Parent Title

  • CLINICAL COLORECTAL CANCER

Volume

  • 17

Issue

  • 4

Publisher

  • CIG Media Group